Early identification of neutropenic patients at risk of grampositive bacteraemia and the impact of empirical administration of vancomycin

Clicks: 489
ID: 117382
1996
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Star

Ranked #1 of 24 articles by views in European journal of cancer (Oxford, England : 1990)

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
The aim of this multicentre randomised trial was to determine whether it was possible to predict grampositive bacteraemia, and whether the empirical use of vancomycin would lead to reduced morbidity and mortality. 35 of 113 patients (31%; confidence interval, CI 8.5), who presented with a skin or so …
Reference Key
ec1996europeanearly Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Dompeling EC;Donnelly JP;Deresinski SC;Feld R;Lane-Allman EF;De Pauw BE;;
Journal European journal of cancer (Oxford, England : 1990)
Year 1996
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/8869095
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine treatment outcome research support non-u.s. gov't adult female male middle aged Skin Diseases Clinical Trial Randomized Controlled Trial Multicenter Study bacteremia / drug therapy* neutropenia / complications* bacterial / drug therapy anti-bacterial agents / therapeutic use* soft tissue infections / drug therapy neoplasms / complications gram-positive bacterial infections / drug therapy* vancomycin / therapeutic use* gram-positive bacterial infections / diagnosis bacteremia / etiology pmid:8869095 doi:10.1016/0959-8049(96)00050-0 e c dompeling j p donnelly b e de pauw gram-positive bacterial infections / etiology opportunistic infections / diagnosis opportunistic infections / drug therapy* opportunistic infections / etiology

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.